Grand River Aseptic Manufacturing, Inc. (GRAM), is a pharmaceutical contract development and manufacturing organization, delivering customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM’s expert project managers and modern facilities support pharmaceutical development and cGMP manufacturing, analytical testing and regulatory filing.
GRAM opened its doors in 2011 and in a period of seven years, GRAM became one of Michigan’s fastest growing companies. Now with revenues between $25 and $50 million, Inc. Magazine named GRAM as the 7th Fastest Growing Company in Michigan with sales growth of 703% for the three-year measurement period ending in 2017. GRAM continues to hold a place on the Inc 5000 List.
GRAM was founded with the support of the local West Michigan community. The predecessor company was formed by Van Andel Institute and GVSU, both of which remain shareholders today. When GRAM was formed in Dec. 2010 with the help of the Charter Group, Grand Angels was one of the primary sponsors.
CEO, Tom Ross states, “Our consistent and continual focus on quality is the primary driver behind our growth. Our additional focus on business development and customer service, implementing expansion plans, our pursuit of operational excellence through continual improvement and ultimately the focus on future growth are the strategies behind this incredible growth story.”
GRAM consistently strives to achieve a culture of Family. Their moniker “GRAMily” represents their focus of inclusiveness. Strategically, there are four tenets for a successful GRAM: Sales, Customer Satisfaction, Employee Satisfaction and Superior Regulatory Performance.
